prodromal symptoms

Related by string. * : prodromal phase . prodromal / SYMPTOMS . Symptoms . Symptom . SYMPTOM . symp toms : urinary tract symptoms . respiratory symptoms . allergy symptoms . experiencing flulike symptoms . neurological symptoms . IBS symptoms . concussion symptoms . relieve menopausal symptoms . alleviate menopausal symptoms . psychotic symptoms . symptom onset . depressive symptoms * *

Related by context. All words. (Click for frequent words.) 67 APTIVUS r 66 syndromal 66 EXJADE 65 prodromal 65 dopaminergic therapy 65 intravitreal injections 65 somatic symptoms 65 atypical antipsychotic medications 65 prodrome 64 antidepressant therapy 64 OSAHS 64 OAB symptoms 64 hyperalgesia 64 INVEGA ® 64 prodromal phase 64 clomipramine 64 Hypotension 64 Suicidal ideation 64 anterior uveitis 64 recurrent glioblastoma multiforme 64 pyridostigmine 64 virological response 64 comorbid disorders 64 postprocedure 64 gout flare 64 ALT flares 63 neurocognitive deficits 63 generalized seizures 63 comorbid depression 63 TEAEs 63 hypochondriasis 63 subsyndromal 63 solifenacin 63 postdischarge 63 desvenlafaxine succinate 63 depressive symptomatology 63 unexplained syncope 63 ziconotide 63 neurologic symptoms 63 PASI scores 63 status epilepticus 63 hypomanic episodes 62 glucocorticoid therapy 62 extrapyramidal symptoms 62 NATRECOR R 62 nonoperative treatment 62 invasive aspergillosis 62 nonadherence 62 sacral neuromodulation 62 neuroleptic 62 ictal 62 neurologic sequelae 62 rebleeding 62 mania hypomania 62 eculizumab therapy 62 asymptomatic AF 62 manic hypomanic 62 AGILECT R 62 generalized tonic clonic seizures 62 opioid dependent 62 symptomatic VTE 62 divalproex sodium 62 euthymic patients 62 episodic migraine 62 overactive bladder symptoms 61 syncopal episode 61 interpersonal psychotherapy 61 perioperatively 61 T2DM 61 postoperative AF 61 knee osteoarthritis OA 61 AGILECT ® 61 recurrent VTE 61 asthma exacerbation 61 poststroke 61 virological failure 61 TMS Therapy 61 proliferative diabetic retinopathy 61 β blockers 61 akinetic mutism 61 affective psychosis 61 Lamictal XR 61 MADRS score 61 T1DM 61 paresthesias 61 hypoperfusion 61 fragility fracture 61 neuropsychiatric symptoms 61 paroxysmal AF 61 opioid analgesia 61 virologic breakthrough 61 NAbs 61 psychodynamic psychotherapy 61 symptomology 61 analgesic medications 61 psychiatric comorbidities 61 severe exacerbations 61 dyspareunia 61 somatization 61 recurrent venous thromboembolism 61 oral anticoagulation 61 syncopal episodes 61 PONV 61 hypokalemia 61 antiarrhythmic drug 61 hypomagnesemia 61 asthma exacerbations 61 RLAI 61 amisulpride 61 RLS symptoms 61 NIHSS score 61 acute gout flares 61 urinary symptoms 61 gout flares 61 Chronic Migraine 61 onset atrial fibrillation 61 chest radiographs 61 aminotransferases 61 morphometric vertebral fractures 60 generalized anxiety disorder GAD 60 hemodynamic instability 60 levodopa therapy 60 intracranial hypertension 60 prazosin 60 syncopal 60 dissociative symptoms 60 parkinsonian symptoms 60 recurrent ischemia 60 myoclonus 60 posttreatment 60 AA Amyloidosis 60 Major Depressive Disorder 60 VFEND 60 underwent resection 60 NATRECOR ® 60 generalized epilepsy 60 adenoidectomy 60 thrombotic complications 60 colorectal liver metastases 60 pentoxifylline 60 postsurgical 60 QTc prolongation 60 severe hypoglycemia 60 Nocturia 60 ICD shocks 60 hyperacute 60 neurocognitive impairment 60 coronary stenoses 60 paroxysmal atrial fibrillation 60 hypomanic symptoms 60 CONCERTA ® 60 concomitant AEDs 60 MBCT 60 gemifloxacin 60 levetiracetam 60 Thal Dex 60 intensive statin therapy 60 somatoform disorders 60 comorbid diagnoses 60 intrathecal baclofen 60 GH deficiency 60 comorbid psychiatric 60 relapsed AML 60 suicide attempters 60 nighttime awakenings 60 Parkinsonian symptoms 60 Heavy menstrual bleeding 60 VIIBRYD 60 allodynia 60 infliximab therapy 60 acute aortic dissection 60 Generalized Anxiety Disorder 60 unipolar depression 60 decompensation 60 VADT 60 psychoeducation 60 oral antidiabetes drugs 60 antiepileptic drugs AEDs 60 aromatase inhibitor therapy 60 KRAS mutations occur 60 abdominal laparoscopic surgery 60 rFVIIa 60 antimuscarinic 60 EDSS scores 60 PREZISTA r 60 somatic complaints 60 symptomatology 60 RRMS patients 60 thunderclap headache 60 rtPA 60 macroalbuminuria 60 parkinsonian 60 HPA axis suppression 60 UA NSTEMI 60 dosage regimens 60 haematologic 60 antithrombotic therapy 60 dysuria 60 nocturnal awakenings 60 postoperative complication 60 upper gastrointestinal bleeding 60 PNES 60 Subgroup analyzes 60 subthreshold depression 60 reflux symptoms 60 proliferative retinopathy 60 PFPS 60 acute gout 60 postintervention 60 abrupt discontinuation 60 neuroleptics 59 CPAP adherence 59 venlafaxine XR 59 recurrent herpes labialis 59 Infusion Reactions Severe 59 LUTS 59 incontinence episodes 59 salmeterol fluticasone 59 corticosteroid therapy 59 CP CPPS 59 subconjunctival hemorrhage 59 GERD symptoms 59 ruboxistaurin 59 clinically meaningful improvements 59 MS relapses 59 EVIZON 59 INVEGA ™ 59 tolterodine ER 59 cognitive behavioral therapies 59 detrusor overactivity 59 subclinical disease 59 post thrombotic syndrome 59 adenotonsillectomy 59 apneic episodes 59 ecchymosis 59 varicella infection 59 ragweed allergic 59 poststroke depression 59 Restless Legs Syndrome RLS 59 clevidipine 59 T2 lesions 59 syncope 59 symptom severity 59 acute psychosis 59 induce orthostatic hypotension 59 guideline concordant 59 reinfarction 59 gross hematuria 59 headache nausea dizziness 59 recurrent abdominal pain 59 psychiatric comorbidity 59 HER2 overexpression 59 primary aldosteronism 59 spontaneous bowel movements 59 sinus rhythm 59 nondepressed 59 MMSE score 59 cystoscopic 59 cerebrovascular events 59 delusions hallucinations 59 diarrhea predominant IBS 59 hypomanic episode 59 IBS symptoms 59 PCNSL 59 stable angina 59 hypofractionated radiation 59 transaminase elevations 59 eosinophilic pneumonia 59 angiographic outcomes 59 subclinical hypothyroidism 59 psychotic symptoms 59 Venous thromboembolism 59 hepatitis C genotype 59 epigastric pain 59 nasal polyposis 59 neurologic dysfunction 59 sustained ventricular tachycardia 59 pathologic fractures 59 nonadherent 59 migraineurs 59 unruptured aneurysm 59 canakinumab 59 Excessive daytime sleepiness 59 lumbar disk herniation 59 thoracoscopic lobectomy 59 HCV antibody 59 perioperative complications 59 urolithiasis 59 anticholinergic drugs 59 antihypertensive therapy 59 nociceptive pain 59 PSVT 59 gouty arthritis 59 PSA nadir 59 emotional lability 59 hepatic encephalopathy 59 hippocampal atrophy 59 conventional antipsychotics 59 nocturnal enuresis 59 chronicity 59 hemorrhagic complications 59 autonomic dysfunction 59 conjunctival hyperemia 59 octreotide LAR 59 SSRI antidepressant 59 anxiolytic 59 periprocedural MI 59 bothersome symptom 59 prescribed antipsychotic medication 59 pharmacologic treatments 59 Afib 59 revascularization procedures 59 oxycodone CR 59 atrioventricular block 59 pericardial effusion 59 euthymic 59 oral corticosteroids 59 acute STEMI 59 citalopram 59 depressive symptom 59 pediatric bipolar disorder 59 somatization disorder 59 SLNB 59 perimenopausal women 59 prolonged QT interval 59 GIST tumors 59 LV dysfunction 59 carotid stenosis 58 evaluable subjects 58 hypoglycemic episodes 58 hepatic metastases 58 HBV infections 58 medically refractory 58 claudication 58 renal scarring 58 venlafaxine Effexor 58 tapentadol ER 58 iloprost 58 dysmenorrhoea 58 postoperative atrial fibrillation 58 Postoperative complications 58 IOP lowering 58 thyrotoxicosis 58 beta blocker therapy 58 pegaptanib 58 reperfusion therapy 58 highly emetogenic 58 psychotic disorders 58 receiving XGEVA 58 asymptomatic PAD 58 ADPKD 58 neuropsychological impairments 58 psychotherapeutic interventions 58 GnRH agonists 58 comorbid anxiety 58 adenomatous polyps 58 androgen excess 58 p = .# [002] 58 fibrinolytic therapy 58 relapsing MS 58 VAPRISOL 58 benign positional vertigo 58 Vimpat ® 58 SSRI SNRI 58 neovascular 58 anticholinergic medication 58 variant angina 58 antiangiogenic therapy 58 EFFEXOR XR 58 ventricular tachyarrhythmia 58 posttransplant 58 timepoint 58 intravenous bisphosphonates 58 riociguat 58 CIMZIA ™ 58 severe hypoglycemic 58 aneurysmal subarachnoid hemorrhage 58 tonic clonic seizures 58 Aggrastat ® tirofiban hydrochloride 58 pharmacotherapies 58 hepatic encephalopathy HE 58 subarachnoid hemorrhage SAH 58 osteoporotic vertebral compression fractures 58 treatment emergent AEs 58 salmeterol HFA MDI 58 hypercalcemia 58 F FDG PET 58 symptom exacerbation 58 Zevalin consolidation 58 intracerebral haemorrhage 58 monoclonal gammopathy 58 constipation OIC 58 subthreshold 58 concomitant antibiotics 58 psychodynamic therapy 58 MIRAPEX 58 invasive fungal infection 58 countertransference 58 paroxetine Paxil 58 bacteriuria 58 alteplase 58 neoadjuvant radiation 58 SCIg 58 ruptured aneurysms 58 periprocedural 58 chronic GVHD 58 aldosterone antagonist 58 NIH CPSI 58 anagrelide 58 Hepatotoxicity 58 paliperidone ER 58 acute mania 58 hyperarousal 58 frequent awakenings 58 sonographic findings 58 post herpetic neuralgia 58 Adjuvant chemotherapy 58 AGHD 58 callus formation 58 SRBD 58 mg kg dose 58 antiepileptics 58 agomelatine 58 medically unexplained 58 chronic periodontitis 58 recurrent glioma 58 recurrent DVT 58 curative resection 58 typical antipsychotics 58 alexithymia 58 vasogenic edema 58 achieved CCyR 58 INVEGA 58 tryptophan depletion 58 interferon ribavirin 58 symptom flare ups 58 thyroid nodules 58 tolterodine 58 laboratory abnormalities 58 urinary leakage 58 temporal arteritis 58 intravenous diuretics 58 somnolence sleepiness 58 Neovascular AMD 58 eosinophilic asthma 58 perfusion defects 58 MGd 58 onset seizures 58 Interpersonal psychotherapy 58 adrenalectomy 58 RISPERDAL ® 58 Ménière disease 58 lipid lowering medications 58 CR nPR 58 Withdrawal symptoms 58 HbA 1c levels 58 paricalcitol 58 VT VF 58 Postoperatively 58 lesional 58 fibrinolysis 58 pre operatively 58 diabetes mellitus DM 58 EDSS score 58 vesicoureteral reflux 58 menopausal symptom 58 Y BOCS 58 demyelinating 58 hemiparesis 58 akathisia 58 diabetic gastroparesis 58 hypocalcemia 58 resynchronization therapy 58 hematologic parameters 58 myofascial pain syndrome 58 hypomania 58 decompensated heart failure 58 variceal bleeding 58 hypoactive 58 ischemic lesions 58 virologic failure 58 hypoglycemic events 58 renal flares 58 anticipatory anxiety 58 subclinical cardiovascular disease 58 TMP SMX 58 malperfusion 58 nonoperative 58 confusional 58 COREG 58 comorbid psychiatric disorders 58 severe hypoglycaemia 58 nausea vomiting headache 58 obstructive sleep 58 MGUS 58 CIN3 58 symptomatic hyponatremia 57 oral corticosteroid 57 NPH insulin 57 overnight polysomnography 57 white matter hyperintensities 57 uncontrolled asthma 57 untreated psychosis 57 arteriography 57 antipsychotic efficacy 57 neurologic deficits 57 dose escalation phase 57 Febrile neutropenia 57 myocardial infarctions 57 premorbid 57 arterial thromboembolic events 57 febrile illness 57 nonresponders 57 interferon therapy 57 trastuzumab Herceptin ® 57 paroxysmal 57 biologic DMARD 57 relapsed MM 57 mild TBI 57 neutropenic fever 57 hepatectomy 57 hematologic toxicity 57 tumor resection 57 extubation 57 adrenal insufficiency 57 elevated IOP 57 idiopathic Parkinson disease 57 risperidone Risperdal 57 haloperidol Haldol 57 candidemia 57 hypoxemia 57 hyperglycaemia 57 intestinal metaplasia 57 nonmetastatic prostate cancer 57 tumor necrosis 57 cerebral angiography 57 HIV HCV coinfected 57 nortriptyline 57 tumor histology 57 CSF biomarkers 57 HBeAg seroconversion 57 cortical stimulation 57 Brief Psychiatric 57 genotypic resistance 57 anemia hemoglobin 57 hepatic toxicity 57 neutropaenia 57 endometrial hyperplasia 57 neurosyphilis 57 dopamine antagonists 57 tricuspid regurgitation 57 quetiapine Seroquel 57 overactive bladder syndrome 57 zolmitriptan 57 psychopharmacological 57 dosing cohorts 57 psychoactive medication 57 exploratory endpoints 57 non affective psychosis 57 hypovolemia 57 adjunctive ABILIFY 57 fibromyalgia syndrome 57 nonpharmacologic interventions 57 androgen deprivation 57 liver metastasis 57 ziprasidone 57 RLS sufferers 57 nocturnal hypoglycemia 57 postexposure prophylaxis 57 C1 INH deficiency 57 vertigo dizziness 57 HBeAg negative 57 florbetaben 57 comorbid conditions 57 MERLIN TIMI 57 NIHSS 57 chronic prostatitis chronic 57 invasive candidiasis 57 ARIXTRA 57 CIPN 57 timepoints 57 Nesiritide 57 convulsive seizures 57 NNT = 57 antiplatelet medication 57 COPD exacerbations 57 EXPAREL 57 recurrent genital herpes 57 colonoscopic 57 ischemic cardiomyopathy 57 follicular lymphomas 57 antidiabetic medication 57 paroxysmal supraventricular tachycardia 57 BoNTA 57 choroidal neovascularization 57 microscopic hematuria 57 moderate renal impairment 57 insulin detemir 57 ipsilateral stroke 57 hyperhydrosis 57 oral anticoagulant therapy 57 chlamydial infection 57 hypertrophic scars 57 seminomas 57 radicular pain 57 juvenile idiopathic arthritis 57 GI motility 57 detectable HCV RNA 57 lipid lowering therapy 57 oral naltrexone 57 ICD implantation 57 postoperative infections 57 neurocognitive functioning 57 Raynaud syndrome 57 prostate cancer CaP 57 VaD 57 fulminant 57 HeFH 57 choroidal vasculopathy 57 noninfectious uveitis 57 constipation nausea 57 thrombolytic therapy 57 oral methylnaltrexone 57 aromatase inhibitors AIs 57 PANSS scores 57 psychiatric outpatients 57 pharmacologic therapies 57 reflux disease GERD 57 hepatic lesions 57 femoral neck fractures 57 Retreatment 57 urate lowering therapy 57 trials RCTs 57 vaccinees 57 cryptogenic 57 vasospasm 57 posttraumatic stress disorder PTSD 57 Alequel 57 bolus dose 57 chronic urticaria 57 superficial bladder cancer 57 antiplatelet drugs 57 pouchitis 57 tranylcypromine 57 symptomatic intracranial 57 cerebral vasospasm 57 zoster 57 esophageal gastric 57 ritonavir boosted protease inhibitor 57 CMV infection 57 ablative therapy 57 Recurrences 57 adalimumab 57 CIN2 + 57 achieved statistical significance 57 antiarrhythmic drugs 57 tardive dyskinesia TD 57 milrinone 57 PSADT 57 immunocompetent 57 bicifadine 57 treprostinil 57 antiemetics 57 paresthesia 57 spirometric 57 prospectively stratified 57 acute myocardial infarction AMI 57 posterior vitreous detachment 57 montelukast 57 somatoform disorder 57 gastro oesophageal reflux 57 dysthymic disorder 57 neurologic complications 57 tipranavir ritonavir 57 anatomical abnormalities 57 nonpharmacologic 57 leucopenia 57 VCUG 57 malignant polyps 57 arterial thickening 57 droperidol 57 nonepileptic seizures 57 Relapsing Remitting Multiple Sclerosis 57 intractable hiccups 57 hyperreflexia 57 definite stent thrombosis 57 aneurysm rupture 57 depression suicidality 57 microalbuminuria 57 intravascular hemolysis 57 MULTAQ 57 conventional angiography 57 posttraumatic stress 57 Helicobacter pylori eradication 57 dysphoric 57 MYCAMINE 57 cerebral atrophy 57 ACTEMRA TM 57 herpetic 57 vulvodynia 57 TURBT 57 pulmonary artery hypertension 57 mild renal insufficiency 57 dystonic 57 DVT PE 57 posttest 57 hematological toxicity 57 pulmonary hypertension PH 57 Potiga 57 ARICEPT 57 aldosterone antagonists 57 ribavirin therapy 57 perfusion abnormalities 57 stratifying patients 57 affective psychoses 57 apneic 57 nonpsychotic 57 laxation 57 eosinophilia 57 NSTEMI 56 osteoporotic compression fractures 56 receiving ISENTRESS 56 STEP BD 56 bowel resection 56 rt PA 56 intravenous IV infusion 56 highly emetogenic chemotherapy 56 androgen suppression 56 cortical activation 56 nonvertebral fracture 56 oral prednisolone 56 anticholinergics 56 Hurthle cell 56 brain lesions 56 cardioembolic stroke 56 sulfasalazine 56 manic episode 56 postop 56 rufinamide 56 doxorubicin HCl 56 postoperative nausea 56 nonalcoholic steatohepatitis NASH 56 sertraline Zoloft 56 urinary incontinence UI 56 Natalizumab 56 quetiapine 56 MMSE scores 56 depressive symptoms 56 Symptom severity 56 hyperactivity inattention 56 exacerbations 56 cholinesterase inhibitor 56 moderately emetogenic 56 postoperative morbidity 56 baseline HbA1c 56 lamotrigine 56 sonographically 56 atherosclerotic renal artery stenosis 56 serum cortisol 56 plain radiographs 56 clinically meaningful improvement 56 AChE inhibitors 56 cerebral ischemic 56 thrombophlebitis 56 antioxidant supplementation 56 Testosterone deficiency 56 IBS C 56 post operatively 56 NeuroStar TMS Therapy 56 Intussusception 56 Neuropsychiatric Inventory NPI 56 antibody titer 56 AZILECT 56 certolizumab 56 chemoradiation therapy 56 Hepatocellular Carcinoma HCC 56 EBV infection 56 argatroban 56 thrombolytic agents 56 refractory epilepsy 56 preoperative MRI 56 ximelagatran 56 non menstrual pelvic 56 mammographically 56 systemic corticosteroid 56 #q# deletion syndrome 56 amnestic MCI 56 habitual snorers 56 comorbid 56 psychotic illness 56 afib 56 nonobstructive CAD 56 myocardial ischemia 56 endophthalmitis 56 sensory neuropathy 56 systolic dysfunction 56 concomitant medications 56 extrapyramidal disorder 56 hyperammonemia 56 psychomotor agitation 56 antithrombotics 56 warfarin therapy 56 apneas 56 preoperative chemotherapy 56 nocebo 56 PRIMO CABG 56 hematuria 56 HAART regimen 56 biochemical relapse 56 placebo controlled clinical 56 acetabular dysplasia 56 GOUT 56 corticosteroid dose 56 hyperprolactinemia 56 silent myocardial ischemia 56 sustained virologic response 56 dysthymia 56 HBeAg 56 febrile seizure 56 premenopause 56 convergence insufficiency 56 pretreatment baseline 56 neuropathic 56 cilostazol 56 progressive dyspnea 56 Obstructive Sleep Apnea OSA 56 meta regression 56 pharmacokinetic interaction 56 neuroleptic drugs 56 adjunctive placebo 56 TMJD 56 SGAs 56 methacholine challenge 56 DAPT 56 cystoid macular edema 56 prescribed beta blocker 56 pseudoaneurysm 56 glycated hemoglobin levels 56 pharmacological interventions 56 impaired cognition 56 COPD exacerbation 56 ADAGIO study 56 visceral metastases 56 null responder 56 aripiprazole 56 syncope fainting 56 endoscopists 56 methotrexate monotherapy 56 psychiatric morbidity 56 cannabinor 56 % CI #.#-#.# [003] 56 premenstrual syndrome PMS 56 clinically meaningful reductions 56 antenatal depression 56 daytime drowsiness 56 #F FDG PET 56 untreated sleep apnea 56 femoral neck fracture 56 intravenous cyclophosphamide 56 expressive aphasia 56 saline infusion 56 Abciximab 56 paragangliomas 56 triamcinolone 56 pulmonary exacerbation 56 NMIBC 56 neuropsychological assessment 56 cecal intubation 56 neostigmine 56 idraparinux 56 androgen ablation 56 zafirlukast 56 dose cohort 56 transurethral resection 56 ventricular fibrillation VF 56 prescribed opioids 56 adnexal mass 56 antiretroviral naive 56 lamivudine refractory patients 56 BENICAR HCT 56 zonisamide SR 56 pramipexole 56 placebo controlled clinical trials 56 DPNP 56 serum phosphorous 56 Anxiety disorders 56 brivaracetam 56 inflammatory lesions 56 dexmedetomidine 56 dose titration 56 Traficet EN 56 herpes zoster shingles 56 ritonavir boosted 56 allogeneic HSCT 56 gastric varices 56 torsade de pointes 56 advanced adenoma 56 Vimpat R 56 Overactive Bladder OAB 56 ADHD symptoms 56 antimicrobial prophylaxis 56 ZOLINZA 56 tracheal intubation 56 hepatorenal syndrome 56 symptomatic paroxysmal AF 56 vagal nerve stimulation 56 thromboembolic 56 pulmonary infiltrates 56 tipranavir r 56 hypersomnia 56 disordered breathing 56 Phase #b/#a trial 56 metastatic uveal melanoma 56 antiplatelet medications 56 Suicidal thoughts 56 ALT elevations 56 atherothrombotic 56 elevated ALT 56 dyspnoea 56 aspartate aminotransferase AST 56 endosonography 56 denervation 56 overt nephropathy 56 Posttraumatic stress disorder PTSD 56 postoperative radiotherapy 56 HAMD 56 KETEK 56 lipid lowering agents 56 biochemical recurrence 56 lipid altering 56 nasal obstruction 56 Abilify aripiprazole 56 heterozygous FH 56 Cortisol levels 56 systemic hypotension 56 extubated 56 mesalamine granules 56 Insulin PH# 56 risperidone olanzapine 56 untreated OSA 56 oxcarbazepine 56 spontaneous regression 56 icatibant 56 enuresis 56 Serious adverse reactions 56 antipsychotic medications 56 nasopharyngitis headache 56 molindone 56 bullous 56 rimonabant #mg 56 cytoreductive surgery 56 anastomotic leak 56 corticosteroid injection 56 allogeneic stem cell 56 hypoventilation 56 ADHF 56 metastatic RCC 56 hyperkalemia 56 pharmacological treatments 56 voiding dysfunction 56 tacrolimus ointment 56 #mg/day [001] 56 psoriatic arthritis PsA 56 LOVENOX R 56 Atypical antipsychotics 56 plasma kallikrein inhibitor 56 diabetic polyneuropathy 56 aspirin regimen 56 cytopenia 56 penicillin allergy 56 Tardive Dyskinesia 56 TNF alpha inhibitor 56 fluoxetine Prozac 56 affective disorder 56 acetabular fractures 56 mucosal healing 56 hypogonadotropic hypogonadism 56 delayed CINV 56 apnea hypopnea 56 Lyme arthritis 56 KRAS mutant tumors 56 nephrotoxicity 56 pheochromocytoma 56 Brodmann Area 56 haematuria 56 hypotensive 56 topical calcineurin inhibitors 56 acupuncture sham acupuncture 56 CANCIDAS 56 overt HE 56 patellar dislocation 56 systolic hypertension 56 antidepressant monotherapy 56 relapsers 56 antiandrogens 56 anal incontinence 56 metastatic malignant melanoma 56 lacunar 56 serum urate levels

Back to home page